Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan-Reference-Cited by-同舟云学术

Is diabetes and hypertension screening worthwhile in resource-limited settings? An economic evaluation based on a pilot of a Package of Essential Non-communicable disease interventions in Bhutan

Published:2014-10-08 Issue:8 Volume:30 Page:1032-1043
ISSN:0268-1080
Container-title:Health Policy and Planning
language:en
Short-container-title:Health Policy Plan.

Author:

Dukpa Wangchuk,Teerawattananon Yot,Rattanavipapong Waranya,Srinonprasert Varalak,Tongsri Watsamon,Kingkaew Pritaporn,Yothasamut Jomkwan,Wangchuk Dorji,Dorji Tandin,Wangmo Kinzang

Publisher

Oxford University Press (OUP)

Subject

Health Policy

Link

http://academic.oup.com/heapol/article-pdf/30/8/1032/1473585/czu106.pdf

Reference30 articles.

1. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

2. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. The Lancet 2000;356:1955-64.

3. Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes

4. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report

5. Role of Intensive Glucose Control in Development of Renal End Points in Type 2 Diabetes Mellitus

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in India;Applied Health Economics and Health Policy;2024-03-07

2. Screening for Hypertension in Asymptomatic Individuals in Nepal: An Expert Consensus Statement;Nepalese Heart Journal;2023-11-05

3. The incremental cost of implementing the world health organization Package of essential non-communicable (PEN) diseases interventions in Iran;PLOS Global Public Health;2023-02-08

4. Programmatic Cost-Effectiveness of a Second-Time Visit to Detect New Tuberculosis and Diabetes Mellitus in TB Contact Tracing in Myanmar;International Journal of Environmental Research and Public Health;2022-12-01

5. Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women;Applied Health Economics and Health Policy;2022-05-10